Carolyne Croizier
Clermont-ferrand, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Burkitt lymphoma: Definition, diagnostic approach, and current therapeutic strategies
Journal: Bulletin du cancer
Published: January 13, 2026
"AMM updates" section of the journal Bulletin du Cancer: Feedback from the contributing authors
Journal: Bulletin du cancer
Published: December 14, 2025
Teclistamab in Elderly Patients With Relapsed/Refractory Multiple Myeloma: A Subgroup Analysis of the French RetrosTECtive Cohort.
Journal: EJHaem
Published: October 16, 2025
Studying daratumumab's interference in serum protein electrophoresis: two case reports
Journal: Annales de biologie clinique
Published: April 07, 2025
Daratumumab, bortezomib, lenalidomide and dexamethasone in patients treated for multiple myeloma eligible for autologous stem cell transplantation
Journal: Bulletin du cancer
Published: January 22, 2025
Contribution of molecular characterization to the diagnosis of MPN in patients with low JAK2V617F variant allelic fraction in a real-world cohort.
Journal: Annals of hematology
Published: December 06, 2024
Multiplex digital PCR enables sensitive detection of resistance to BTK inhibitors.
Journal: Annals of hematology
Published: November 15, 2024
Elranatamab monotherapy in the real-word setting in relapsed-refractory multiple myeloma: results of the French compassionate use program on behalf of the IFM.
Journal: Blood cancer journal
Published: October 06, 2024
Teclistamab in relapsed refractory multiple myeloma: a multi-institutional real-world study from the French early access program.
Journal: Haematologica
Published: July 20, 2024
Elranatamab monotherapy in multiple myeloma after at least three prior treatments
Journal: Bulletin du cancer
Published: May 14, 2024
Last Updated: 09/26/2026